InvestorsHub Logo
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: Gold Seeker post# 27592

Monday, 11/08/2010 11:54:24 AM

Monday, November 08, 2010 11:54:24 AM

Post# of 30387
Gold, that is correct. It would be very good news if this new patent is just expanding on the abstract's content, b/c then we are closer than I thought being granted that patent. The clock starts when the provisional patent is applied for, which according to Goldseeker is a year ago. That is news to me and I owe Gold an apology for the Roche article, although his intent was to say we are a long ways off. IMO, if Dr Moro can demonstrate to a major biotech/pharma company his discovery and can claim he is protected by a worldwide patent, it will be a huge windfall for shareholders. Lot's of ifs and I'll admit nothing is certain, but I would also state as a matter of fact that Biocurex has turned the page and the prize could be much more significant.
Gold, how can you argue now how valuable a universal cancer marker will be in locating and irradicating all types of cancer. Now add to that the fact that recaf has the ability to identify cancer in the earliest stages, so in my mind the lightbulb went off yesterday and I was thinking maybe it is possible that some day all of us could just take a pill PREVENTATIVELY that finds the cancer and destroys it without causing any side effects and risk of the cancer growing or spreading. Talk about revolutionary and one of the most significant breakthroughs in the history of mankind. How do like them apples?
You have to put into perspective that Dr Moro has the knowledge and abilities to see this thru. I know, and Gold knows because we both had a conversation with Dr Moro and at that time he envisioned a cure utilizing recaf many years ago and now he has found a method that could make it possible. How can I not be ecstatic?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.